Health-related quality-of-life improvements in CIDP with immune globulin IV 10%: the ICE Study. / Merkies, Isj; Bril, V; Dalakas, Mc; Deng, C; Donofrio, P; Hanna, K; Hartung, Hp; Hughes, Rac; Latov, N; Vandoorn, Pa; Barroso, F; Nogués, M; Rivero, A; Marchesoni, C; Pardal, Am; Reisin, R; Dubrovsky, A; Villa, A; Chapman, K; Gibson, G; Adamova, B; Bednarik, J; Vohanka, S; Ehler, E; Haas, J; Munch, C; Artamonov, I; Drory, V; Groozman, G; Buchman, A; Chapman, J; Uncini, A; Benedetti, L; Ghiglione, E; Mancardi, G; Narciso, E; Schenone, A; Comi, G; Dacci, P; Delcarro, U; Fazio, R; Malaguti, Mc; Riva, N; Ruizsandoval, Jl; Fryze, W; Szczudlik, A; Banach, M; Selmaj, K; Bogucki, A; Zielinska, M; Stelmasiak, Z; Bartosikpsujek, H; Belniak, E; Chyrchel, U; Kaminski, M; Kosterapruszczyk, A; Kwiecinski, H; Apostolski, S; Basta, I; Divac, V; Trikic, R; Oh, S; Caress, J; Cho, S; Patwa, H; Tsao, B; Thomas, F; Trivedi, J; Wolfe, G.. - In: NEUROLOGY. - ISSN 0028-3878. - STAMPA. - 72(2009), pp. 1337-1344.